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Abstract
We investigated the population structure of Staphylococcus aureus clonal complex CC121 by mutation discovery at 115
genetic housekeeping loci from each of 154 isolates, sampled on five continents between 1953 and 2009. In addition, we
pyro-sequenced the genomes from ten representative isolates. The genome-wide SNPs that were ascertained revealed the
evolutionary history of CC121, indicating at least six major clades (A to F) within the clonal complex and dating its most
recent common ancestor to the pre-antibiotic era. The toxin gene complement of CC121 isolates was correlated with their
SNP-based phylogeny. Moreover, we found a highly significant association of clinical phenotypes with phylogenetic
affiliations, which is unusual for S. aureus. All isolates evidently sampled from superficial infections (including staphylococcal
scalded skin syndrome, bullous impetigo, exfoliative dermatitis, conjunctivitis) clustered in clade F, which included the
European epidemic fusidic-acid resistant impetigo clone (EEFIC). In comparison, isolates from deep-seated infections
(abscess, furuncle, pyomyositis, necrotizing pneumonia) were disseminated in several clades, but not in clade F. Our results
demonstrate that phylogenetic lineages with distinct clinical properties exist within an S. aureus clonal complex, and that
SNPs serve as powerful discriminatory markers, able to identify these lineages. All CC121 genomes harboured a 41-kilobase
prophage that was dissimilar to S. aureus phages sequenced previously. Community-associated MRSA and MSSA from
Cambodia were extremely closely related, suggesting this MRSA arose in the region.
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Introduction
Staphylococcus aureus is one of the most common human
pathogens and causes a wide range of infections, from skin and
soft tissue infections (SSTIs) to life threatening diseases such as
pneumonia, endocarditis, bacteremia and toxic-shock syndrome
[1,2]. Among SSTI, two clinical entities predominate: (i)
superficial infections that affect the upper skin layers exclusively
(stratum corneum and stratum granulosum) and (ii) deep-seated
infections associated with formation of abscesses such as furuncles,
whitlows, and sweat-gland abscesses [3,4]. Superficial infections
are associated with formation of exfoliative toxins, most commonly
exfoliative toxins A (ETA) and B (ETB) [5–9]. Exfoliative toxins
are structurally related to a family of serine proteases and
associated with the binding and cleavage of desmosomal
cadherins, in particular desmoglein-1 (Dsg-1). The degradation
of Dsg-1 provokes splitting of the granular cell layer in the
epidermis, which causes blistering and exfoliation of the skin
[5,10]. The diseases associated with this mechansim are staphy-
lococcal scalded skin syndrome (SSSS) and bullous impetigo. On
the other hand, deep-seated infections are frequently caused by S.
aureus strains that produce the Panton-Valentine leukocidin toxin
(PVL) [4,6,11]. PVL is a bicomponent, pore-forming cytotoxin
composed of two contiguous protein components (LukF-PV of
34 kDa and LukS-PV of 33 kDa). The destructive capability of
PVL arises from the PVL-mediated lysis and apoptosis of
polymorphonuclear leukocytes (PMNs or neutrophils) [12]. The
two components LukF-PV and LukS-PV assemble into a pore-
forming heptamer on the surface of PMNs, leading to PMN lysis
and to the activation of several mechanisms (e.g. release of reactive
oxygen species, inflammatory response) which contribute to tissue
necrosis [13].
PLOS ONE | www.plosone.org 1 March 2013 | Volume 8 | Issue 3 | e58155
The association of the two different clinical manifestations of S.
aureus infections with either exfoliative toxins ETA and ETB or the
PVL toxin, respectively, is particularly well documented for S.
aureus clonal complex CC121 [4,14–16]. Complex CC121 is
globally distributed, colonizing the anterior nares of asymptomatic
subjects [14,17–21]; however, it is also a common cause of both
superficial skin infections [9,14,15] and deep-seated infections
[4,14–16]. Commonly, CC121 isolates are susceptible to methi-
cillin. Recently, however, methicillin resistance had been found in
CC121 among community-associated methicillin-resistant S. aureus
(caMRSA) from Cambodia [19].
In the present study, we examined the population structure of
CC121 on the basis of polymorphisms discovered in 115 genetic
loci scattered around the staphylococcal genome. We reconstruct-
ed the evolutionary origin of caMRSA from PVL-producing
methicillin-susceptible S. aureus in South-East Asia. We demon-
strate that distinct phylogenetic lineages within CC121 are
associated with specific courses of disease.
Results and Discussion
Global Population Structure
We tested for sequence polymorphisms at 115 housekeeping loci
of about 400 basepairs each (Table S1), in total covering about
1.7% (46,811 basepairs) of the genome from each of 154 S. aureus
CC121 isolates. Among these isolates, 138 displayed sequence type
ST121, the presumed ancestral type of clonal complex CC121
(Table S2). Eleven isolates displayed various single-locus variants
of ST121, and five isolates displayed ST123, a double-locus
variant (Table S2). Onehundred-fiftythree isolates had been
sampled between 1987 and 2009 in 27 countries on five continents
(Table S2). In addition, we included the phage-propagating strain
PS71 from approximately 1953 [22]. We identified 304 single-
nucleotide polymorphisms, 5 insertions and 7 deletions ranging in
size from 1 to 12 basepairs (Table S3). SNPs included 93
synonymous base substitutions and 211 non-synonymous substi-
tutions (Table S3). Based on these polymorphisms, our 154 isolates
were assigned to 121 haplotypes (Figure 1). Ninety-two SNPs were
parsimony-informative (i. e., the respective derived alleles were
found in more than one haplotype) and the level of homoplasy was
very low (homoplasy index, 0.03). The nucleotide diversity = was
0.0002660.00001, which is nearly three times higher than the
nucleotide diversity for S. aureus ST5 [23]. A SNP-based,
maximum-likelihood phylogenetic analysis revealed at least six
major clades, A to F, within S. aureus CC121 (Figure 1).
We applied a Bayesian coalescent method of phylogenetic
inference implemented in the BEAST program [24] to estimate
evolutionary rates and divergence times for CC121. Based on our
set of DNA sequences from isolates that had been sampled
between 1953 and 2009 (Table S2), we estimated the nucleotide
substitution rate at 261026 substitutions per nucleotide site per
year (95% confidence intervals, 1.261026 to 2.861026). This
short-term evolutionary rate is similar to rates previously reported
for S. aureus [25,26]. Based on this rate and the sequence variation
observed in our dataset, the most recent common ancestor of
CC121 was dated to 1884 (95% confidence interval, 1827 to
1925). This age estimate should be interpreted with caution
because it is based on a relatively long extrapolation from available
sequence data (note the large confidence interval). However, it is
several fold longer than estimates available for MRSA [25–27],
which might reflect the widespread endemic nature of S. aureus
CC121 that precedes the antibiotic era.
The 154 isolates of our study displayed 38 different spa types,
with six spa types covering 67% of all isolates (Figure S1). Some spa
types were restricted to particular phylogenetic clades (t314 to
clade B, t940 to clade C, t435 to clade D). However, the
association of several other spa types (t284, t170, t272, t2155) with
SNP-based phylogeny was imperfect, as each of them was found in
several, unrelated haplotypes (Figure S2). The maximum mono-
phyletic clade (MC) statistics calculated for these spa types by using
BaTS software [28] confirmed the absence of significant associ-
ations with phylogeny, because they were not significantly different
from MC values for a randomized, null distribution (Table S4).
These results suggested spa homoplasies, similar to previous reports
on other S. aureus sequence types [23,25,29].
Phylogeography
The isolates’ phylogenetic relationships reflect their geographic
origin to a considerable extent, suggesting that specific subclones
of CC121 are endemic in the regions sampled (Figure 1).
Accordingly, for several geographic regions, Bayesian analysis
with BaTS software indicated associations of geographic origins
with phylogeny (Table S4). For example, clade A encompasses all
12 isolates from Oceania, including strains from New Zealand,
Samoa, Tonga and Fiji. Similarly, clade C encompasses six out of
seven isolates from South America, including Peru, Panama,
Paraguay and the Bahamas. Further, all 20 isolates in clade E are
from Southeast-Asia, including Thailand and Cambodia, clade B
contains most of the isolates from Africa (Nigeria, Uganda, Togo,
South Africa and Kenya), and clades D and F contain isolates
mostly from Europe. Isolates from Europe are comparatively more
diverse (Figure 1), possibly due to more extensive sampling
coverage from this region, as 45% of the isolates originate from
Europe.
The epidemic European fusidic acid-resistant impetigo clone
(EEFIC), which is characterized by exfoliative toxin production,
the fusB gene and, most commonly, spa type t171 [15], is a
subclone of clade F (Figure 1). Evidently, EEFIC has spread
clonally throughout several European countries [30,31], and here
we report that EEFIC has been present also in Germany and the
Czech Republic since at least 2007 and 2005, respectively (Table
S2).
Our analysis included five isolates of ST121 community-
associated MRSA from Cambodia, which had been reported only
recently [19,32]. These MRSA isolates are very closely related to
each other and to MSSA from the same area, displaying a
maximum distance of only one point mutation in the 47 kb of
DNA analysed (Figure 1). This result suggests that ST121 MRSA
arose locally in Cambodia (and only once), which had been
assumed previously based on the high prevalence of methicillin-
susceptible S. aureus (MSSA) ST121 in the country and similar
antibiotic resistance patterns among MRSA ST121 and MSSA
ST121 from the same geographic region [19].
Comparative Genomics
We pyro-sequenced the genomes from ten CC121 isolates,
including the oldest isolate in the collection, which had been
collected in 1953, and one to three isolates from each of the
phylogenetic clades A to F (Figure 1). Genome-wide SNPs from
these selected isolates were ascertained by mapping sequencing
reads onto an ST5 reference sequence by using SSAHA2 software.
These SNPs largely confirmed the phylogenetic relationships that
had been revealed from 47-kb sequences from the larger set of
isolates, including the relatedness of MRSA and MSSA from
Cambodia (Figure 1, Figure 2). However, genome sequences
provided more precise estimates of internodal distances and
indicated that clades A, B, and C are related and clades D and E
are related (Figure 2), which had not been resolved on the basis of
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more limited data (Figure 1). Genome sequences provided no
evidence of recombination (homoplasy index, 0.05; no recombi-
nation detected with Recombination Detection Program RDP
3.44). In addition, sequencing reads were assembled de-novo by
applying Newbler software, revealing the gene content for each of
the sequenced genomes (Table S6). All CC121 isolates harboured
a 41-kb prophage that was dissimilar from S. aureus phages
sequenced previously with respect to DNA sequence, gene
content, integrase group, and capsid-gene based phage type
(Table S5). The prophage encoded 55 open-reading frames, most
of which could not be assigned any specific functions based on
sequence similarity (Figure S3). CC121 genomes contained one to
three additional prophages, including an integrase group Sa1
phage encoding the eta gene or a group Sa2 phage encoding the
PVL gene (Table S6). Each genome had three pathogenicity
islands (SaPI), with strain-specific variation (Table S6). MRSA
carried a methicillin-resistance island that shared .99% sequence
similarity with previously reported SCCmecV (sequence accession
number GQ902038 [33]).
Because methicillin-resistant CC121 had not been found until
recently, we investigated whether CC121 genomes may lack the
DNA sequences necessary for integration of the SCCmec element
(the genetic determinant of methicillin resistance in staphylococci).
SCCmec integrates into a specific attachment site (attB) at the 3’-
end of a gene named orfX in the staphylococcal chromosome, and
it has been proposed that the core of the attachment site itself and
the 100 basepairs left from it need to be highly conserved to enable
efficient insertion or excision of the SCCmec element [34]. In the
ten genomes we have sequenced, this chromosomal region was
identical to that from another ST121 isolate [34], except for a
single point mutation in two ST121-MRSA and their close,
methicillin-susceptible relative from Cambodia, indicating that the
attB sequence in CC121 does not prevent SCCmec integration. It
has also been proposed that a presumptive mobile genetic element
encoding an enterotoxin gene (seh) interferes with SCCmec motility,
when inserted downstream of the SCCmec attachment site [35]. All
of our CC121 genomes had a similar element at this position,
encoding a different enterotoxin gene. However, this element was
also present in ST121-MRSA, so it does not appear to hinder
integration of SCCmec in CC121.
Correlation of Clinical Phenotype and Toxin Gene
Complement with Phylogeny
Bayesian analysis by using BaTS software indicated that the
isolate toxin gene complement was strongly associated with their
SNP-based phylogeny, because the MC values calculated for the
presence of the toxin genes, the association index (AI) and the
parsimony score (PS) all were significantly different from statistics
estimated for a null distribution; p#0.01; Table S4). Clade F
encompassed 35 isolates, 21 of which carried the exfoliative toxin
genes eta and etb, ten carried either one of the two, and four tested
Figure 1. Phylogenetic relationships of 154 CC121 isolates. Maximum-likelihood phylogenetic tree based on 304 SNPs ascertained in 115
genetic loci (47 kb total) and annotated with the country of origin and year of isolation. The continent of origin is indicated by the color of the
isolate’s name: blue, Europe; orange, Asia; green, Oceania; red, North America; yellow, South America; black, Africa. Bootstrap values are shown where
$85%. The scale bar represents substitutions per SNP site. Asterisks indicate isolates selected for whole-genome sequencing. The European epidemic
fusidic acid-resistant impetigo clone (EEFIC) was identified on the basis of fusidic acid resistance, PCR detection of the fusB gene, spa typing (t171),
and MLST (ST123).
doi:10.1371/journal.pone.0058155.g001
Figure 2. Maximum-likelihood phylogenetic tree based on an alignment of 1,828 SNPs ascertained in 2,209 kb from pyro-
sequenced genomes. Bootstrap values .90% are indicated.
doi:10.1371/journal.pone.0058155.g002
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negative for both, eta and etb (Figure 3). We noted that three clade
F isolates (97-01548, 97-01848-1, 00-01004-1) were etb-negative
now, even though they had been tested etb-positive several years
ago according to records in our strain collection database,
presumably reflecting the instability of the etb carrying plasmid
during long-term storage or sub-cultivation. None of the isolates in
clade F tested positive for the lukS/F gene encoding the PVL toxin.
In contrast, isolates outside of clade F were preferentially linked
with the presence of the lukS/F genes (Figure 3). Upon sequencing
the lukS/F genes, we identified sequence variants R, H1, H2, and
H3, all of which had been reported previously to be present in
multiple other clonal complexes of S. aureus (24), plus six novel
sequence variants (Table S7), indicating that CC121 has acquired
the lukS/F-carrying phage multiple times.
It is not clear why lukS/F and eta/etb genes are mutually
exclusive in CC121. LukS/F and eta reside on unrelated prophages
that integrate at different positions into the genome, and etb is
commonly encoded by a plasmid, whose mode of interaction with
prophages is not known. We noted that one of the genomes from
clade F (isolate 09-00227 with eta) lacked the attachment site for
the lukS/F-carrying phage [36] due to a deletion event. However,
by using a dedicated PCR (Table S8), we found that this deletion
was not a common feature of clade F isolates. Rather, the
attachment site was present in all clade F isolates except for those
affiliated to the EEFIC clade (Figure 1) and one other isolate. It is
possible that the observed association between gene complement
and phylogeny is driven simply by the extensive international
spread of clonal strains that carry one or other toxin genes, rather
than any mechanistic hindrances to gene acquisition (Figure 1,
Figure 3). For example, antibiotic usage promotes the spread of
resistant S. aureus strains, but in our sample of CC121 no specific
resistance traits were associated with clade F (Table S2).
Reportedly, Staphylococcus aureus strains with exfoliative toxins
frequently also produce EDIN exotoxins [37]. Because the exact
role of EDIN in staphylococcal infections has not yet been
explored, this issue was not followed here.
We were able to ascertain the type of disease associated with 46
of the isolates in our international CC121 collection. Of these, 35
infections could be unequivocally classified as either superficial or
deep-seated, whereas 11 were wound infections or unspecified
’skin and soft tissue infections’ (Table S2). Strikingly, all isolates
associated with superficial infections (n = 14) (including SSSS,
bullous impetigo, exfoliative dermatitis, and one case of conjunc-
tivitis) clustered in clade F (Figure 3). In contrast, isolates from
deep-seated infections (n = 21) (abscesses, furuncles, pyomyositis,
necrotizing pneumonia) were disseminated in several clades, but
not in clade F (Figure 3). Accordingly, the association of the
clinical phenotype with the phylogenetic affiliation of the
respective isolates was highly significant (i. e., MC, AI, and PS
statistics were significantly different from those for a null
distribution; p#0.01; Table S4).
Links between specific types of disease and phylogenetic
groupings within the species S. aureus have been highly unusual
findings in the past. For example, MLST-defined clonal lineages of
S. aureus generally do not correlate with virulence properties or
with any other phenotypic traits that may be of interest to
clinicians [38]. Our results demonstrate that S. aureus strains with
specific clinical properties exist within clonal complexes, and that
SNPs may be powerful discriminatory markers to identify them
(Table S9). In the light of accelerated and abundant pathogen
genome sequencing [25], we anticipate that additional S. aureus
strains with association to specific clinical symptoms may be
recognized in the future, and that (SNP-based) typing could
eventually be used to predict the pathogenic potential of a given
isolate. In many cases, however, the propensity to cause a specific
clinical picture will depend on interactions between multiple
proteins rather than a single toxin.
Methods
Bacterial Isolates
The sources and characteristics of S. aureus isolates are provided
in Table S2. Some of these isolates had been included in previous
studies as indicated in Table S2 [16,19,22,32,39]. To represent
global diversity, we included 154 isolates from 27 countries on five
continents. Antimicrobial susceptibility was tested by using the
microbroth dilution method according to DIN58940 and applying
the EUCAST breakpoints. Spa-typing was performed according to
the Ridom StaphType standard protocol (www.ridom.org) and
spa-types were assigned using the respective StaphType software
(Ridom GmbH, Würzburg, Germany). MLST was performed as
described previously [40]. Primers for the detection of eta-, etb- and
lukSF-PV-genes are summarized in Table S8. The different lukSF-
PV sequence variants were determined as specified by OHara et al.
[41].
Mutation Discovery by dHPLC
Mutation discovery was performed as described previously
[23,42]. Briefly, PCR-amplified gene fragments were analyzed by
dHPLC (WaveR Nucleic Acid Fragment Analysis System,
Transgenomic). The 115 genetic loci investigated, PCR primers,
and dHPLC conditions are listed in Table S1. Subsequently,
mutations were verified in all affected isolates by capillary
sequencing. Discovered polymorphisms and their properties are
summarized in Table S3.
Data Analysis
Sequences from 115 loci were concatenated for each of 154
isolates, resulting in a 46,811-bp sequence alignment. A maximum
likelihood tree based on this alignment was constructed with
PhyML 3.0.1. The ancestral node was determined by including
the genome sequence from distantly related S. aureus N315 (ST5;
GenBank accession number BA000018). DnaSP was used to
calculate the mean pair-wise distance between alleles at synony-
mous (Ks) and non-synonymous (Ka) sites and to estimate the
nucleotide diversity (p) and nucleotide variation (hw) [43]. The
homoplasy index was estimated with Paup 4.0. Short-term
evolutionary rates and divergence dates were estimated by
applying the BEAST software, version 1.6.2 (http://beast.bio.ed.
ac.uk/) [24], dating sequences with the year of isolate sampling,
and running 108 iterations after a burn-in phase of 106 iterations.
BEAST results were virtually independent from applied clock
models (strict, relaxed) and tree priors (constant population size,
Bayesian skyline).
We applied Bayesian tip-association significance testing (BaTS,
version 1.0; [28]) to assess phylogeny-trait associations for clinical
phenotypes, toxin gene complement, spa types, geographic origin,
and antimicrobial resistance, each based on sets of 100 trees
sampled from BEAST results. In each case, isolates for which the
respective trait information was not available had been excluded
from the initial sequence alignments. The association index (AI),
the parsimony score (PS), and the maximum monophyletic clade
(MC) statistics were computed [28]. To avoid any inflation of the
statistical significance of associations due to multiple, indistin-
guishable isolates in the dataset, calculations were repeated after
excluding redundant isolates, and both sets of statistics are
reported (Table S4). The null hypothesis of no association between
phylogeny and traits was estimated on the basis of 100
Staph. aureus Phylogeny and Clinical Phenotype
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Figure 3. Toxin gene complement and clinical phenotype. Maximum likelihood phylogenetic tree as in Figure 1, indicating the presence of
toxin genes lukSF-PV, eta, and etb (colours) and clinical phenotype where this was reported (symbols: {, superficial infection, i. e., impetigo,
staphylococcal scalded skin syndrome, conjunctivitis, or exfoliative dermatitis); {, deep-seated infection (abscess, furuncle, pyomyositis, necrotizing
pneumonia).
doi:10.1371/journal.pone.0058155.g003
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randomizations, and the null hypothesis was rejected if p,0.05
(Table S4).
Genome Sequencing
Staphylococcal genome sequences were generated commercially
(GATC, Konstanz, Germany) on a 454 FLX machine, applying
FLX+ chemistry and resulting in 12- to 21-fold average coverage.
De-novo assemblies with 454 Newbler software resulted in 68 to
156 contigs (.500 bp) per genome. Sequence annotation was
performed by comparisons to previously published S. aureus
genomes, applying the annotation tool implemented in Kodon
software (Applied Maths), and by BLAST searches in the
GenBank database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). In
addition, prophage sequences were identified with PHAST (phage
search tool, available at http://phast.wishartlab.com/[44]). Ge-
nome-wide SNPs were ascertained by mapping the sequencing
reads onto the N315 genome sequence (GenBank accession
number BA000018), applying SSAHA2 software (available at
http://www.sanger.ac.uk/resources/software/ssaha2/) and filter-
ing the resulting output for SNPs with a minimum consensus
quality of 30, a minimum mapping quality of 30, and a minimum
coverage of 5. SNPs in mobile genetic elements (SaPIs, prophages,
transposons, IS elements), repetitive regions, homopolymeric
regions, and within 100 bp from contig ends were removed
manually, resulting in a dataset of 1,828 SNPs ascertained in the
core genome of 2,208,736 basepairs. An alignment of core genome
sequences from ten CC121 isolates and from the reference N315
was used to reconstruct a maximum likelihood phylogenetic tree
with PhyML3.01. The Recombination Detection Program (RDP
3.44, [45]) was applied to screen the alignment for evidence of
recombination based on the RDP, Geneconv, Chimaera, MaxChi,
Bootscan, and SiScan methods (see RDP manual), applying
default parameters and p,0.05.
Sequence data has been deposited at the NCBI Sequence Read
Archive (http://www.ncbi.nlm.nih.gov/sra) under accession num-
bers SRX209921 to SRX209927, SRX208966, and SRX209760.
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